AstraZeneca | AZN - EPS Earnings Per Share


AstraZeneca reported $2.58 in EPS Earnings Per Share for its fiscal quarter ending in March of 2026.


Fiscal Calendar Actual Consensus Previous Date
FY2026Q1 Mar/2026 2.58 2.5 2.49 Apr/29
FY2025Q4 Dec/2025 2.12 2.13 2.09 Feb/10
FY2025Q3 Sep/2025 2.38 2.3 2.08 Nov/06
FY2025Q2 Jun/2025 2.17 2.21 1.98 Jul/29
FY2025Q1 Mar/2025 2.49 2.24 2.06 Apr/29




Eps Change Date
AbbVie USD 2.65 0.06 Mar/2026
Alcon AG USD 0.85 0.07 Mar/2026
Almirall EUR 0.07 0.03 Dec/2025
Amgen USD 5.15 0.14 Mar/2026
argenx SE USD 4.7 2.1 Mar/2026
AstraZeneca USD 2.58 0.46 Mar/2026
Autolus Therapeutics Ltd USD -0.27 0.07 Mar/2026
Bayer EUR 2.71 2.09 Mar/2026
Biogen USD 3.57 1.58 Mar/2026
Bristol-Myers Squibb USD 1.58 0.32 Mar/2026
Eli Lilly USD 8.55 1.01 Mar/2026
Fresenius EUR 0.82 0.04 Mar/2026
Fresenius Medical Care EUR 0.91 0.53 Mar/2026
Genmab DKK 3.69 2.77 Dec/2025
Gilead Sciences USD 2.03 0.17 Mar/2026
GlaxoSmithKline GBP 0.43 0.17 Mar/2026
GRIFOLS EUR 0.14 0.11 Mar/2026
Haleon GBP 0.05 0 Mar/2026
Hikma Pharmaceutical USD 0.65 0.12 Dec/2025
Lakefront Biotherapeutics EUR -0.84 12.73 Mar/2026
Lonza CHF 6.07 1.92 Jun/2025
Merck EUR 2.11 0.23 Mar/2026
Merck USD -1.28 3.32 Mar/2026
Novartis USD 1.99 0.04 Mar/2026
Orion EUR 0.66 1.19 Mar/2026
Pfizer USD 0.75 0.09 Mar/2026
Philips EUR 0.23 0.37 Mar/2026
Recordati EUR 0.73 0 Mar/2026
Regeneron Pharmaceuticals USD 9.47 1.97 Mar/2026
Roche Holding CHF 8.37 2.95 Dec/2025
Sanofi EUR 1.88 0.35 Mar/2026
UCB EUR 5.65 3.21 Dec/2025